News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
859,787 Results
Type
Article (77830)
Company Profile (359)
Press Release (781575)
Multimedia
Podcasts (285)
Webinars (44)
Section
Business (259590)
Career Advice (3861)
Deals (39128)
Drug Delivery (247)
Drug Development (89205)
Employer Resources (212)
FDA (18565)
Job Trends (17177)
News (387104)
Policy (38745)
Tag
2025 Best Places to Work (24)
2026 Best Places to Work (37)
2027 BioCapital Standard (5)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (9)
2027 Biotech Beach Standard (6)
2027 Genetown Elite (2)
2027 Genetown Standard (6)
2027 NextGen (1)
2027 Pharm Country Digital (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (5)
40 Under 40 (4)
Academia (3112)
Academic (2)
Accelerated approval (77)
ADA (54)
Adcomms (44)
Allergies (237)
Alliances (56004)
ALS (292)
Alzheimer's disease (2166)
Antibody-drug conjugate (ADC) (780)
Approvals (19171)
Artificial intelligence (1097)
ASCO (349)
Autoimmune disease (540)
Automation (86)
Bankruptcy (395)
Belgium (45)
Best Places to Work (12622)
BIO (82)
Biologics (124)
Biomarkers (1)
BIOSECURE Act (23)
Biosimilars (309)
BioSpace Insights (271)
Biotechnology (241)
Bispecific (64)
Bladder cancer (251)
Brain cancer (103)
Breast cancer (983)
Cancer (8081)
Cardiovascular disease (687)
Career advice (3350)
Career pathing (65)
CAR-T (465)
CDC (82)
CDMO (240)
Celiac Disease (9)
Cell-line development (2)
Cell therapy (1261)
Cervical cancer (69)
Clinical research (78950)
Collaboration (2908)
Commercialization (77)
Company closure (10)
Compensation (1950)
Complete response letters (129)
COVID-19 (3087)
CRISPR (155)
CRO (10)
C-suite (1722)
Cystic fibrosis (183)
Data (11240)
Decentralized trials (4)
Denatured (113)
Depression (229)
Dermatology (210)
Diabetes (850)
Diagnostics (7947)
Digital health (86)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (538)
Drug pricing (254)
Drug shortages (41)
Duchenne muscular dystrophy (389)
Earnings (100800)
Editorial (85)
Employer branding (27)
Employer resources (184)
ESMO (440)
Events (138417)
Executive appointments (1386)
Eye disease (28)
FDA (23696)
Fibrodysplasia Ossificans Progressiva (17)
Fragile X (6)
Friedreich's ataxia (29)
Frontotemporal dementia (43)
Funding (2384)
Gene editing (323)
Generative AI (103)
Gene therapy (988)
GLP-1 (1420)
Government (5595)
Grass and pollen (8)
Guidances (446)
Healthcare (21499)
Hematology (239)
HIV (126)
Huntington's disease (94)
Idiopathic pulmonary fibrosis (16)
IgA nephropathy (155)
Immunology and inflammation (432)
Immuno-oncology (167)
Indications (303)
Infectious disease (3546)
Inflammatory bowel disease (285)
Inflation Reduction Act (17)
Influenza (167)
Intellectual property (391)
Interviews (755)
IPO (17845)
IRA (61)
Job creations (4823)
Job search strategy (2671)
JPM (73)
Kidney cancer (31)
Kidney disease (183)
Labor market (154)
Layoffs (732)
Leadership (70)
Legal (9693)
Licensing (141)
Liver cancer (121)
Longevity (57)
Lung cancer (1115)
Lung diease (27)
Lymphoma (572)
Machine learning (77)
Management (72)
Manufacturing (1655)
Marketing (42)
MASH (261)
Medical affairs (6)
Medical device (15447)
Medtech (15788)
Melanoma (237)
Mergers & acquisitions (22855)
Metabolic disorders (2173)
Middle East (2)
mRNA (348)
Multiple sclerosis (264)
Multispecific (7)
NASH (24)
Netherlands (44)
Neurodegenerative disease (642)
Neuropsychiatric disorders (154)
Neuroscience (4384)
Neurotech (3)
NextGen: Class of 2026 (7600)
Non-profit (5176)
Now hiring (103)
Obesity (1031)
Opinion (411)
Ovarian cancer (302)
Pain (354)
Pancreatic cancer (463)
Parkinson's disease (494)
Partnered (51)
Patents (814)
Patient advocacy (9)
Patient recruitment (989)
Patient selection (124)
Peanut (81)
People (67760)
Peptides (47)
Pharmaceutical (68)
Pharmacy benefit managers (43)
Phase 1 (24465)
Phase 2 (34393)
Phase 3 (26046)
Pipeline (14821)
Policy (435)
Postmarket research (3177)
Preclinical (10695)
Press Release (74)
Prostate cancer (413)
Psychedelics (105)
Radioligand (3)
Radiopharmaceuticals (451)
Rare diseases (1623)
Real estate (7155)
Recruiting (84)
Regenerative medicine (39)
Regulatory (31183)
Reports (102)
Research institute (2816)
Resumes & cover letters (612)
Rett syndrome (60)
RNA editing (39)
RSV (107)
Saudi Arabia (1)
Schizophrenia (231)
Series A (411)
Series B (287)
Series C (1)
Service/supplier (16)
Sickle cell disease (152)
Special edition (38)
Spinal muscular atrophy (200)
Sponsored (61)
Startups (4236)
State (2)
Stem cells (8)
Stomach cancer (24)
Substance use disorders (23)
Supply chain (175)
Switzerland (24)
Tariffs (109)
Tax incentives (2)
The Weekly (169)
Vaccines (1454)
Venture capital (188)
Weight loss (684)
Wet AMD (8)
Women's health (191)
Women in leadership (2)
Worklife (28)
Date
Today (107)
Last 7 days (746)
Last 30 days (3964)
Last 365 days (33584)
2026 (30832)
2025 (32440)
2024 (37489)
2023 (42549)
2022 (53911)
2021 (58699)
2020 (57643)
2019 (51287)
2018 (39076)
2017 (36793)
2016 (37500)
2015 (44135)
2014 (39297)
2013 (35161)
2012 (35618)
2011 (35618)
2010 (34001)
Location
Africa (1215)
Alabama (118)
Alaska (7)
Arizona (479)
Arkansas (17)
Asia (51374)
Australia (8755)
California (17386)
Canada (4758)
China (2072)
Colorado (775)
Connecticut (778)
Delaware (549)
Europe (116973)
Florida (2643)
Georgia (567)
Hawaii (5)
Idaho (70)
Illinois (1488)
India (156)
Indiana (787)
Iowa (36)
Japan (788)
Kansas (161)
Kentucky (68)
Louisiana (71)
Maine (99)
Maryland (2045)
Massachusetts (12554)
Michigan (465)
Minnesota (950)
Mississippi (8)
Missouri (192)
Montana (38)
Nebraska (31)
Nevada (209)
New Hampshire (93)
New Jersey (4607)
New Mexico (38)
New York (4532)
North Carolina (2249)
North Dakota (14)
Northern California (8913)
Ohio (541)
Oklahoma (32)
Oregon (55)
Pennsylvania (3328)
Puerto Rico (38)
Rhode Island (65)
South America (1592)
South Carolina (105)
South Dakota (2)
Southern California (6957)
Tennessee (290)
Texas (2888)
United States (61573)
Utah (531)
Vermont (2)
Virginia (437)
Washington D.C. (90)
Washington State (1385)
West Virginia (4)
Wisconsin (200)
Wyoming (6)
859,787 Results for "vetter pharma fertigung gmbh and co kg".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Vetter’s V-OVS® next earns prestigious Red Dot Design Concept Award
Novel syringe closure system honored for its innovative design and enhanced user experience · Award recognizes innovative design concept · New syringe closure system builds on more than two decades of market success
October 15, 2026
·
3 min read
Mergers & acquisitions
5 acquisitions that forced Big Pharmas to co-parent
Acquiring a biotech with an existing Big Pharma partner can impose financial and strategic constraints around data sharing and milestone and royalty payments—but it is “rarely a deal-breaker,” according to one biotech consultant.
November 18, 2026
·
8 min read
·
Tristan Manalac
Press Releases
Vetter Recognized as 2026 CDMO Leadership Awards Winner
Independent recognition strengthens Vetter’s position as a trusted, high-performing CDMO • Awards recognize CDMO performance in five categories • Selection is based on quantitative metrics and verified sponsor feedback from biopharma partners • Recognition reflects trust placed in Vetter by industry and customers
March 30, 2026
·
1 min read
Press Releases
Pharmaceutical Service Provider Vetter Pharma to Build New Manufacturing Site in Germany
Strategic Investments in the EU and US strengthen Vetter’s Global Footprint • Building permit application for German site submitted • Construction start is scheduled for the 2nd quarter 2026, with operational readiness in 2031 • Expansions in the US and Europe are included in a €1.5 billion investment plan
January 29, 2026
·
1 min read
Press Releases
Vetter expands global manufacturing network to support future customer needs
Strategic investments strengthen resilience and service capabilities for innovative injectable therapies · First of ten additional commercial manufacturing lines already operational · Continued expansion of global filling capabilities · Ongoing investments strengthen flexibility, resilience, and supply security
September 29, 2026
·
1 min read
Press Releases
Medicus Pharma to Highlight Rationale for CD228V Co-Development and License Agreement
November 9, 2026
·
17 min read
Press Releases
TME Pharma Signs Binding Exclusive Negotiation Agreement with Japanese TMS Co., Ltd.
October 29, 2026
·
7 min read
Press Releases
Kaigene Enters into Exclusive Global Licensing Agreement with Celltrion for Next-Generation Anti-APRIL Antibody KG013
October 22, 2026
·
4 min read
Press Releases
Vetter Achieves Platinum Status as a Best Managed Company
Pharmaceutical service provider receives prestigious management award for the seventh year in a row · Family-owned company once again excels in all four key business areas · Site development and digitalization as strategic investment priorities · Focus on new sources for skilled workers and on lifelong learning
May 26, 2026
·
1 min read
Press Releases
PepGen Announces Positive Phase 2 FREEDOM2-DM1 10 mg/kg Results Demonstrating Highest Reported Splicing Correction and Improvements Across Multiple Functional Measures
November 10, 2026
·
12 min read
1 of 85,979
Next